Is Okta a Good Stock to Buy?
Okta (NASDAQ:OKTA) is used by some of the largest firms…
Sell
38
ALGN Quote, Financials, Valuation and Earnings
Last price:
$153.53
Seasonality move
:
12.46%
Day range:
$143.00 - $155.40
52-week range:
$143.00 - $331.64
Dividend yield:
0%
P/E ratio:
27.36x
P/S ratio:
2.88x
P/B ratio:
2.93x
Volume:
2.2M
Avg. volume:
1.3M
1-year change:
-51.26%
Market cap:
$11.3B
Revenue:
$4B
EPS (TTM):
$5.61
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
ALGN
Align Technology
|
$977.9M | $2.02 | -1.71% | 44.8% | $249.30 |
|
BSX
Boston Scientific
|
$4.6B | $0.67 | 16.07% | 222.09% | $115.46 |
|
NVST
Envista Holdings
|
$608.2M | $0.21 | -2.29% | 51.15% | $21.33 |
|
RMD
ResMed
|
$1.3B | $2.36 | 7.21% | 15.65% | $269.42 |
|
STE
Steris PLC
|
$1.5B | $2.60 | 3.71% | 63.48% | $250.13 |
|
XRAY
Dentsply Sirona
|
$854.8M | $0.30 | -10.31% | 232.77% | $20.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
ALGN
Align Technology
|
$153.51 | $249.30 | $11.3B | 27.36x | $0.00 | 0% | 2.88x |
|
BSX
Boston Scientific
|
$89.70 | $115.46 | $132.4B | 71.76x | $0.00 | 0% | 7.96x |
|
NVST
Envista Holdings
|
$15.48 | $21.33 | $2.7B | -- | $0.00 | 0% | 1.07x |
|
RMD
ResMed
|
$205.17 | $269.42 | $30.1B | 24.22x | $0.53 | 1.01% | 6.14x |
|
STE
Steris PLC
|
$212.61 | $250.13 | $20.9B | 45.14x | $0.57 | 1.05% | 3.91x |
|
XRAY
Dentsply Sirona
|
$13.58 | $20.00 | $2.7B | -- | $0.16 | 4.71% | 0.73x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
ALGN
Align Technology
|
-- | 2.064 | -- | 1.02x |
|
BSX
Boston Scientific
|
32.79% | 0.797 | 8.05% | 0.46x |
|
NVST
Envista Holdings
|
32.21% | 1.303 | 41.98% | 1.63x |
|
RMD
ResMed
|
11.35% | 0.237 | 2% | 1.74x |
|
STE
Steris PLC
|
25.22% | 0.755 | 10.71% | 1.20x |
|
XRAY
Dentsply Sirona
|
52.37% | 0.294 | 56.57% | 0.55x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
ALGN
Align Technology
|
$696.9M | $177.1M | 11.12% | 11.12% | 17.79% | $263.1M |
|
BSX
Boston Scientific
|
$3.1B | $790M | 5.97% | 8.96% | 14.58% | $1.2B |
|
NVST
Envista Holdings
|
$372.5M | $67.7M | -22.7% | -32.33% | 7.11% | $123.8M |
|
RMD
ResMed
|
$751.3M | $417.2M | 21.74% | 25.56% | 32.54% | $285.2M |
|
STE
Steris PLC
|
$610.3M | $247.5M | 5.15% | 7.27% | 18.08% | $243.6M |
|
XRAY
Dentsply Sirona
|
$446M | $9M | -18.42% | -32.39% | -56.02% | $36M |
Align Technology vs. Competitors
-
Which has Higher Returns ALGN or BSX?
Boston Scientific has a net margin of 10.43% compared to Align Technology's net margin of 12.41%. Align Technology's return on equity of 11.12% beat Boston Scientific's return on equity of 8.96%.
Company Gross Margin Earnings Per Share Invested Capital ALGNAlign Technology70.03% $1.39 $3.9B BSXBoston Scientific67.86% $0.38 $32.6B -
What do Analysts Say About ALGN or BSX?
Align Technology has a consensus price target of $249.30, signalling upside risk potential of 62.4%. On the other hand Boston Scientific has an analysts' consensus of $115.46 which suggests that it could grow by 28.72%. Given that Align Technology has higher upside potential than Boston Scientific, analysts believe Align Technology is more attractive than Boston Scientific.
Company Buy Ratings Hold Ratings Sell Ratings ALGNAlign Technology10 5 0 BSXBoston Scientific23 4 0 -
Is ALGN or BSX More Risky?
Align Technology has a beta of 1.728, which suggesting that the stock is 72.834% more volatile than S&P 500. In comparison Boston Scientific has a beta of 0.728, suggesting its less volatile than the S&P 500 by 27.188%.
-
Which is a Better Dividend Stock ALGN or BSX?
Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Align Technology pays -- of its earnings as a dividend. Boston Scientific pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ALGN or BSX?
Align Technology quarterly revenues are $995.2M, which are smaller than Boston Scientific quarterly revenues of $4.6B. Align Technology's net income of $103.8M is lower than Boston Scientific's net income of $566M. Notably, Align Technology's price-to-earnings ratio is 27.36x while Boston Scientific's PE ratio is 71.76x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 2.88x versus 7.96x for Boston Scientific. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ALGNAlign Technology2.88x 27.36x $995.2M $103.8M BSXBoston Scientific7.96x 71.76x $4.6B $566M
-
Which has Higher Returns ALGN or NVST?
Envista Holdings has a net margin of 10.43% compared to Align Technology's net margin of 0.18%. Align Technology's return on equity of 11.12% beat Envista Holdings's return on equity of -32.33%.
Company Gross Margin Earnings Per Share Invested Capital ALGNAlign Technology70.03% $1.39 $3.9B NVSTEnvista Holdings57.05% $0.01 $4.3B -
What do Analysts Say About ALGN or NVST?
Align Technology has a consensus price target of $249.30, signalling upside risk potential of 62.4%. On the other hand Envista Holdings has an analysts' consensus of $21.33 which suggests that it could grow by 37.81%. Given that Align Technology has higher upside potential than Envista Holdings, analysts believe Align Technology is more attractive than Envista Holdings.
Company Buy Ratings Hold Ratings Sell Ratings ALGNAlign Technology10 5 0 NVSTEnvista Holdings3 10 1 -
Is ALGN or NVST More Risky?
Align Technology has a beta of 1.728, which suggesting that the stock is 72.834% more volatile than S&P 500. In comparison Envista Holdings has a beta of 1.120, suggesting its more volatile than the S&P 500 by 12.044%.
-
Which is a Better Dividend Stock ALGN or NVST?
Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Envista Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Align Technology pays -- of its earnings as a dividend. Envista Holdings pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ALGN or NVST?
Align Technology quarterly revenues are $995.2M, which are larger than Envista Holdings quarterly revenues of $652.9M. Align Technology's net income of $103.8M is higher than Envista Holdings's net income of $1.2M. Notably, Align Technology's price-to-earnings ratio is 27.36x while Envista Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 2.88x versus 1.07x for Envista Holdings. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ALGNAlign Technology2.88x 27.36x $995.2M $103.8M NVSTEnvista Holdings1.07x -- $652.9M $1.2M
-
Which has Higher Returns ALGN or RMD?
ResMed has a net margin of 10.43% compared to Align Technology's net margin of 26.88%. Align Technology's return on equity of 11.12% beat ResMed's return on equity of 25.56%.
Company Gross Margin Earnings Per Share Invested Capital ALGNAlign Technology70.03% $1.39 $3.9B RMDResMed58.6% $2.34 $5.9B -
What do Analysts Say About ALGN or RMD?
Align Technology has a consensus price target of $249.30, signalling upside risk potential of 62.4%. On the other hand ResMed has an analysts' consensus of $269.42 which suggests that it could grow by 31.32%. Given that Align Technology has higher upside potential than ResMed, analysts believe Align Technology is more attractive than ResMed.
Company Buy Ratings Hold Ratings Sell Ratings ALGNAlign Technology10 5 0 RMDResMed8 6 1 -
Is ALGN or RMD More Risky?
Align Technology has a beta of 1.728, which suggesting that the stock is 72.834% more volatile than S&P 500. In comparison ResMed has a beta of 0.755, suggesting its less volatile than the S&P 500 by 24.514%.
-
Which is a Better Dividend Stock ALGN or RMD?
Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ResMed offers a yield of 1.01% to investors and pays a quarterly dividend of $0.53 per share. Align Technology pays -- of its earnings as a dividend. ResMed pays out 27.65% of its earnings as a dividend. ResMed's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ALGN or RMD?
Align Technology quarterly revenues are $995.2M, which are smaller than ResMed quarterly revenues of $1.3B. Align Technology's net income of $103.8M is lower than ResMed's net income of $344.6M. Notably, Align Technology's price-to-earnings ratio is 27.36x while ResMed's PE ratio is 24.22x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 2.88x versus 6.14x for ResMed. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ALGNAlign Technology2.88x 27.36x $995.2M $103.8M RMDResMed6.14x 24.22x $1.3B $344.6M
-
Which has Higher Returns ALGN or STE?
Steris PLC has a net margin of 10.43% compared to Align Technology's net margin of 12.66%. Align Technology's return on equity of 11.12% beat Steris PLC's return on equity of 7.27%.
Company Gross Margin Earnings Per Share Invested Capital ALGNAlign Technology70.03% $1.39 $3.9B STESteris PLC44.53% $1.75 $8.6B -
What do Analysts Say About ALGN or STE?
Align Technology has a consensus price target of $249.30, signalling upside risk potential of 62.4%. On the other hand Steris PLC has an analysts' consensus of $250.13 which suggests that it could grow by 17.65%. Given that Align Technology has higher upside potential than Steris PLC, analysts believe Align Technology is more attractive than Steris PLC.
Company Buy Ratings Hold Ratings Sell Ratings ALGNAlign Technology10 5 0 STESteris PLC2 4 0 -
Is ALGN or STE More Risky?
Align Technology has a beta of 1.728, which suggesting that the stock is 72.834% more volatile than S&P 500. In comparison Steris PLC has a beta of 0.873, suggesting its less volatile than the S&P 500 by 12.657%.
-
Which is a Better Dividend Stock ALGN or STE?
Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Steris PLC offers a yield of 1.05% to investors and pays a quarterly dividend of $0.57 per share. Align Technology pays -- of its earnings as a dividend. Steris PLC pays out 53.03% of its earnings as a dividend. Steris PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ALGN or STE?
Align Technology quarterly revenues are $995.2M, which are smaller than Steris PLC quarterly revenues of $1.4B. Align Technology's net income of $103.8M is lower than Steris PLC's net income of $173.5M. Notably, Align Technology's price-to-earnings ratio is 27.36x while Steris PLC's PE ratio is 45.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 2.88x versus 3.91x for Steris PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ALGNAlign Technology2.88x 27.36x $995.2M $103.8M STESteris PLC3.91x 45.14x $1.4B $173.5M
-
Which has Higher Returns ALGN or XRAY?
Dentsply Sirona has a net margin of 10.43% compared to Align Technology's net margin of -47.51%. Align Technology's return on equity of 11.12% beat Dentsply Sirona's return on equity of -32.39%.
Company Gross Margin Earnings Per Share Invested Capital ALGNAlign Technology70.03% $1.39 $3.9B XRAYDentsply Sirona49.28% -$2.16 $4.1B -
What do Analysts Say About ALGN or XRAY?
Align Technology has a consensus price target of $249.30, signalling upside risk potential of 62.4%. On the other hand Dentsply Sirona has an analysts' consensus of $20.00 which suggests that it could grow by 47.28%. Given that Align Technology has higher upside potential than Dentsply Sirona, analysts believe Align Technology is more attractive than Dentsply Sirona.
Company Buy Ratings Hold Ratings Sell Ratings ALGNAlign Technology10 5 0 XRAYDentsply Sirona2 12 0 -
Is ALGN or XRAY More Risky?
Align Technology has a beta of 1.728, which suggesting that the stock is 72.834% more volatile than S&P 500. In comparison Dentsply Sirona has a beta of 0.918, suggesting its less volatile than the S&P 500 by 8.232%.
-
Which is a Better Dividend Stock ALGN or XRAY?
Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Dentsply Sirona offers a yield of 4.71% to investors and pays a quarterly dividend of $0.16 per share. Align Technology pays -- of its earnings as a dividend. Dentsply Sirona pays out -13.85% of its earnings as a dividend.
-
Which has Better Financial Ratios ALGN or XRAY?
Align Technology quarterly revenues are $995.2M, which are larger than Dentsply Sirona quarterly revenues of $905M. Align Technology's net income of $103.8M is higher than Dentsply Sirona's net income of -$430M. Notably, Align Technology's price-to-earnings ratio is 27.36x while Dentsply Sirona's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 2.88x versus 0.73x for Dentsply Sirona. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ALGNAlign Technology2.88x 27.36x $995.2M $103.8M XRAYDentsply Sirona0.73x -- $905M -$430M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Fidelity High Dividend ETF a Good Investment Now?
Fidelity’s High Dividend ETF (FDVV) is a fund that offers…
Is Kinder Morgan Dividend Yield Worth It?
Kinder Morgan (NYSE:KMI) is a major energy infrastructure company in…
Stock Ideas
Sell
37
Is AAPL Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 31x
Sell
37
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 30x
Sell
31
Is NVDA Stock a Buy?
Market Cap: $2.3T
P/E Ratio: 32x
Alerts
Sell
45
RGC alert for Apr 5
Regencell Bioscience Holdings [RGC] is up 32.59% over the past day.
Sell
25
GDXU alert for Apr 5
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 27.33% over the past day.
Buy
76
SOXS alert for Apr 5
Direxion Daily Semiconductor Bear 3X Shares [SOXS] is up 23.96% over the past day.
